VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Sanofi vs Sea Limited
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Sanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Sea Limited
SE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sanofi leads (74 / 100 vs 69 / 100 for Sea Limited).
- Segment focus: Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)); Sea Limited has 3 segments (73.8% in Shopee (E-commerce)).
- Moat breadth: Sanofi has 5 moat types across 3 domains; Sea Limited has 6 across 3.
Primary market context
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Sea Limited
Shopee (E-commerce)
E-commerce marketplace and related value-added services
Southeast Asia, Taiwan, Brazil
Consumers and sellers
Marketplace operator
73.8%
Side-by-side metrics
Moat coverage
Shared moat types
Sanofi strengths
Sea Limited strengths
Segment mix
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Sea Limited segments
Full profile >Shopee (E-commerce)
Oligopoly
SeaMoney (Digital Financial Services)
Competitive
Garena (Digital Entertainment)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.